← All newsNewswireDefence Therapeutics Inc. Class A (CSE:DTC)September 8, 2026 at 3:15 AM EDTDefence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to ShareholdersSource:Newsfilevia QuoteMediaOriginal releaseThe full release text is being published and will appear here shortly.NewsfileCopyright (c) 2026 QuoteMedia, Inc.
